Guinness Ventures

"There was an area to go and help these pharma companies do better clinical trials, and so that’s how the company started"

"It’s not great being the person doing the onboarding, but equally not great being the person going through the onboarding"

"We have a structural problem in mental health: demand is infinite, capacity is finite. The answer isn’t choosing between technology and therapists, it’s using technology to reach millions of people who will never see a therapist. Clinically governed mental health content, embedded inside the digital experiences people already use, is how we close that gap. But this isn’t just a mental health story, it’s a digital engagement story too. Organisations want their users to actually engage with what they build. JAAQ is the platform that makes both happen, safely and at scale."

"Together with genetics, the concept of personalised medicine requires a dynamic approach. Genomics provides the blueprint of where we begin, but health is not static—it evolves with time, environment, and lifestyle. To truly transform care, we must complement genomic insights with modifiable biomarkers: biological signals that capture real-time responses to interventions and track improvement longitudinally. This synergy between genomics and adaptive biomarkers is the cornerstone for turning personalised medicine from a descriptive concept into actionable, measurable, and preventative healthcare."

"We couldn't be happier to be partnering with Puma on this opportunity. We have the team, the tech, the market size and therefore the opportunity to build a $bn business helping brands launch and scale in the world's largest ecommerce market. We needed an investor who matched YASO's ambitions, and we have found that in Puma. We are also delighted with the other co-investors, including the Seed investors, both VCs and Angels, who have been there since day 1, who backed us again in this round. We can't wait to take YASO to the next level!"